Q9999 is the authoritative medical code for Injection, ustekinumab-aauz otulfi, biosimilar, 1 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, ustekinumab-aauz otulfi, biosimilar, 1 mg (HCPCS Level II Q9999), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, ustekinumab-aauz otulfi, biosimilar, 1 mg is a HCPCS Level II code Q9999 for a Medicare-covered supply, service, or procedure. Short description: Inj ustekinumab-aauz 1 mg.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to Q9999 in its code family, with their registry titles.
- Q9950 — Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954 — Oral magnetic resonance contrast agent, per 100 ml
- Q9955 — Injection, perflexane lipid microspheres, per ml
- Q9956 — Injection, octafluoropropane microspheres, per ml
- Q9957 — Injection, perflutren lipid microspheres, per ml
- Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
View all 40 codes in the Q9950 family